Novartis in Novel Therapeutic Cancer Vaccine Deal with Transgene
By PharmaDeals Analyst
Pharma Deals Review: Vol 2010 Issue 3 (Table of Contents)
Published: 31 Mar-2010
DOI: 10.3833/pdr.v2010.i3.1324 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Transgene SA have signed an exclusive option agreement with Novartis for the worldwide licensing rights to an experimental cancer vaccine, TG4010...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS